RECRUITINGINTERVENTIONAL
Walking Program in Fatty Liver Children With Phenylketonuria
Walking Program in Fatty Liver Children With Phenylketonuria: Response of Liver Enzymes
About This Trial
phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver
Who May Be Eligible (Plain English)
Who May Qualify:
- PKU children
- obese children
- fatty liver children (non-alcoholic fatty liver)
Who Should NOT Join This Trial:
- cardiac children
- diabetic children
- neurogenic disorders
- respiratory and renal problems
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* PKU children
* obese children
* fatty liver children (non-alcoholic fatty liver)
Exclusion Criteria:
* cardiac children
* diabetic children
* neurogenic disorders
* respiratory and renal problems
Treatments Being Tested
BEHAVIORAL
walking free online supervised program
this Group I will include PKU children sufferers (n=20) with non-alcoholic fatty liver that will perform walking program (online supervised free walking that will be applied daily for eight weeks)
Locations (1)
Cairo University
Dokki, Giza Governorate, Egypt